Skip to main content
ABPO logo

ABPO · Abpro Holdings, Inc.

Track ABPO — free
$0.19 -0.03 (-11.68%) At close · Sep 3
Market Cap
$1.35M
Shares
5.90M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.19 Open$0.20 Day$0.19–0.20 Since split$0.10–7.04 Avg vol 30d8K Short int16K · 0.3% float · 1.0d Short vol25% DataNov 2025–Sep 2026 Filing10-Q · Aug 14

Raw chart and full-history price indicators begin at the captured split on Nov 3, 2025; bars on opposite sides are not compared.

The closing range begins at the captured split on Nov 3, 2025.

Up next

filed Aug 14, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
Trailing 12 months
Net income (TTM)
$2.01M
Trailing 12 months
Revenue growth YoY
+50.0%
Year over year
Operating margin
-5,421.3%
Trailing 12 months
P / E (TTM)
0.1
Trailing earnings · reciprocal yield 1,111.7%
FCF yield
TTM · current market cap
Return on invested capital
Trailing 12 months
Net cash
$4.24M
Latest balance sheet
Dividend yield
Trailing 12 months
Shares change YoY
+207.5%
Year over year · more shares
Price change (1Y)
Trailing year
Short interest
0.3%
Latest settlement · 1.0 days to cover
View all 114 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Neutral Sentiment Bearish Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 14.5 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −86%
below
Price vs 50-day avg −8%
below
RSI (14) 45
neutral
MACD trend Negative
52-week position 1%
near low
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Neutral
1-month return −7%
trailing
6-month return +59%
trailing
YTD return −95%
this year
Relative strength +43%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow Distributing
-89% holders QoQ · +1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.28% of float · ▲ +26.8% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
4 holders — near 3-yr low, contrarian setup
Squeeze score 32
low risk · 0–100
Fundamentals
Strong
Revenue growth +50%
Y/Y
EPS growth +94%
Y/Y
Free cash flow $-6.1M
Quant / Vol
risk profile
Very High
Volatility 202%
annualized · 1-yr
Max drawdown −99%
past year
ATR 12.8%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
4 · 2 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−86% Bearish
Price vs 50-day avg
−8% Bearish
RSI (14)
45 Neutral
MACD trend
Negative Bearish
52-week position
1% Bearish
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow Distributing
-89% holders QoQ · +1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.28% of float · ▲ +26.8% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
4 holders — near 3-yr low, contrarian setup
Price context
position in its range since split · 2025-11-03
Range low $0 Now $0 · 1% Range high $7
vs 200-day avg -86% vs 50-day avg -8%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ABPO
Abpro Holdings, Inc.
this stock
$1.35M -95.4% +50.0% 0.3%
VRTX
Vertex Pharmaceuticals Inc / Ma
$138.42B +20.5% +46.2% 31.8 1.6%
REGN
Regeneron Pharmaceuticals, Inc.
$85.22B +7.2% +20.8% 20.5 2.3%
ARGX
Argenx SE
$64.25B +22.9% 1.9%
CSLLY
Csl Ltd
$60.55B 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
4
% held
7.3%
Net QoQ
-8.3M sh
Top holder
Diametric Capital, LP
Held Float
View
Short & Settlement
Short Interest Rising
Shares short
16.5K
Days to cover
1.0d
Change
+3.5K sh
View
Short Volume
Short vol %
25%
As of
Sep 3, 2026
Short Total
View
Fails to Deliver
FTD shares
747
Value
$149
As of
Jun 17, 2026
View
Off-Exchange
Off-exchange %
99.8%
Week of
Jul 27, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$183.0K
Net income (FY)
$2.8M
EPS diluted
$-1.30
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 1, 2026
This year
12
View

Performance

Raw-price comparisons begin at the captured split on Nov 3, 2025; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
ABPO -11.7% -7.5% +59.3% -20.4% -95.4%
SPY +0.3% +0.6% +16.7% +0.8% +13.4%
vs SPY -12.0% -8.1% +42.5% -21.2% -108.8%
Key facts CIK 1893219 CUSIP 000847202 Visit website